---
title: "Texas Capital Bancshrs Pref Share TCBIO 5.75 Perp 06/15/26 B | 10-Q: FY2025 Q2 EPS: USD 1.58"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249028963.md"
datetime: "2025-07-17T20:08:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249028963.md)
  - [en](https://longbridge.com/en/news/249028963.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249028963.md)
generator: "portal-rs"
---

# Texas Capital Bancshrs Pref Share TCBIO 5.75 Perp 06/15/26 B | 10-Q: FY2025 Q2 EPS: USD 1.58

EPS: As of FY2025 Q2, the actual value is USD 1.58.

EBIT: As of FY2025 Q2, the actual value is USD 102.19 M.

### Segment Revenue

-   **Interest Income**: Total interest income for the three months ended June 30, 2025, was $439.567 million, compared to $422.068 million for the same period in 2024. For the six months ended June 30, 2025, total interest income was $866.856 million, compared to $839.446 million for the same period in 2024.

### Operational Metrics

-   **Net Interest Income**: Net interest income for the three months ended June 30, 2025, was $253.395 million, compared to $216.582 million for the same period in 2024. For the six months ended June 30, 2025, net interest income was $489.429 million, compared to $431.591 million for the same period in 2024.
-   **Provision for Credit Losses**: Provision for credit losses for the three months ended June 30, 2025, was $15 million, compared to $20 million for the same period in 2024. For the six months ended June 30, 2025, provision for credit losses was $32 million, compared to $39 million for the same period in 2024.
-   **Non-interest Income**: Non-interest income for the three months ended June 30, 2025, was $54.069 million, compared to $50.424 million for the same period in 2024. For the six months ended June 30, 2025, non-interest income was $98.513 million, compared to $91.743 million for the same period in 2024.
-   **Non-interest Expense**: Non-interest expense for the three months ended June 30, 2025, was $190.276 million, compared to $188.409 million for the same period in 2024. For the six months ended June 30, 2025, non-interest expense was $393.296 million, compared to $390.802 million for the same period in 2024.

### Cash Flow

-   **Net Cash Provided by Operating Activities**: For the six months ended June 30, 2025, net cash provided by operating activities was $63.365 million, compared to $129.091 million for the same period in 2024.
-   **Net Cash Used in Investing Activities**: For the six months ended June 30, 2025, net cash used in investing activities was - $1,644.610 million, compared to - $1,781.461 million for the same period in 2024.
-   **Net Cash Provided by Financing Activities**: For the six months ended June 30, 2025, net cash provided by financing activities was $1,082.579 million, compared to $1,322.599 million for the same period in 2024.

### Unique Metrics

-   **Loans Held for Investment**: Total loans held for investment were $23.925 billion at June 30, 2025, an increase from $22.450 billion at December 31, 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The Company aims to maintain its liquidity strategy by focusing on customer deposits, supplemented by short-term borrowings and long-term debt. The Company also plans to continue its share repurchase program, which allows for repurchase of up to $200 million in shares of its outstanding common stock.
-   **Non-Core Business**: The Company may consider raising additional capital through public or private offerings of debt or equity securities to supplement deposits and meet its long-term funding needs.

### Related Stocks

- [TCBIO.US](https://longbridge.com/en/quote/TCBIO.US.md)

## Related News & Research

- [Oil set for second weekly rise as unsettled US-Iran war crimps supply](https://longbridge.com/en/news/296555193.md)
- [IREN Just Passed Its Biggest AI Test as Microsoft and Nvidia Bet Billions](https://longbridge.com/en/news/296533962.md)
- [Google Is Reportedly Working with AMD for Its New TPU. What This Means for AMD Stock.](https://longbridge.com/en/news/296528134.md)
- [Trump Boosted INTC and DELL: Now He Says ‘Do Magnets’—Are MP and USAR Stocks Next?](https://longbridge.com/en/news/296591886.md)
- [Why Iovance Biotherapeutics Stock Hit 52-Week High](https://longbridge.com/en/news/296522969.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**